Home Test Search Results Factor XIII (13) Activity – Quantitative
Factor XIII (13) Activity – Quantitative

Justification

Factor XIII deficiency is an autosomal recessive disorder that results in internal bleeding, including brain hemorrhaging, following even mild trauma. Continued bleeding may lead to formation of large cysts that may damage bone and nerves. Infants born with Factor XIII deficiency may bleed from the umbilical cord. Affected females have high risk for miscarriage if not receiving treatment, while affected males may be sterile. Treatment includes infusion of fresh or frozen blood or Factor XIII concentrates.

STAT: < 1 week

ELISA

Draw Tube: Blue Top

Sample Type: Citrated Plasma

Specimen Requirements

Sample Type Volume Required Minimum Volume Stability
PREFERRED Citrated Plasma 1mL 0.5mL Frozen (-20C): 2 weeks
Frozen (-80C): 6 months
ALTERNATIVE - - - -
REJECTION CRITERIA Thawed in transit, refrozen or clotted sample
SPECIAL INSTRUCTIONS -

General Information

METHODOLOGY ELISA
STAT TAT < 1 week
STAT TAT Performance > 90% of results released in 1 week
ROUTINE TAT < 1 week
ALTERNATIVE NAMES F13, FXIII
DESCRIPTION -
LIMITATIONS -
NORMAL RANGE -
ASSOCIATED TESTING -
REFERENCES -
SAMPLE REPORT Upon request
NEW YORK STATE APPROVED No

Test Codes

ORDER CODE P3302
CPT CODE 85290
LOINC CODE 3241-7